Development and Commercialization of Biosimilars in India - The author aims to present the current status of India in this context, the challenges that need to be overcome, and some recommendations th

ADVERTISEMENT

Development and Commercialization of Biosimilars in India
The author aims to present the current status of India in this context, the challenges that need to be overcome, and some recommendations that may alleviate these challenges.


BioPharm International
Volume 24, Issue 11, pp. 36-40

REFERENCES

1. G. Walsh, Nature Biotechnol. 28 (9) 917–924 (2010).

2. J. Hodgson, Nature Biotechnol. 27 (11) 963–965 (2009).

3. P. Narang, Datamonior Biosimilar Series 2008 (Datamonitor, London. June 2009).

4. C. Chakraborty and G. Agoramoorthy, Biotechnology Advances 28 (1) 1–6 (2010).

5. S. Chaturvedi, The Indian Jrnl. of Labour Econ. 52 (2) 693–712 (2009).

6. S. Natesh and M. Bhan, Current Sci. 97, 157–169 (2009).

7. C.J. Mathew, Business Standard (Oct. 2007), p. 16.

8. K. Jayaraman, Nature Biotechnol. 28 (9) 883–884 (2010).

9. E.S. Langer, Gen. Engin. & Biotechnol. News 30 (5) 2010

10. A.S. Rathore, Trends in Biotechnol, 27, (12) 698–705 (2009).

11. A.S. Rathore and I.S. Krull, LCGC North America 28, 598–600 (2010).

12. J.F. Tremblay, Chemical & Engin. News (Aug. 2010), p. 23.

13. A. S. Rathore and H. Winkle H, Nature Biotechnol. 27 (1) (2009) 26–34 (2009).

14. A.S. Rathore, Trends in Biotechnology, 27 (9), 546–553 (2009).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines
Source: BioPharm International,
Click here